Literature DB >> 31988691

Future Directions in Cardio-Oncology.

Barry H Trachtenberg1.   

Abstract

Keywords:  cardio-oncology; cardiotoxicity; genetic; genomics; immunotherapy

Mesh：

Substances：

Year:  2019        PMID： 31988691      PMCID： PMC6977570          DOI： 10.14797/mdcj-15-4-300

Source DB:  PubMed          Journal:  Methodist Debakey Cardiovasc J        ISSN： 1947-6108


× No keyword cloud information.
  13 in total

1.  Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.

Authors:  Paul W Burridge; Yong Fuga Li; Elena Matsa; Haodi Wu; Sang-Ging Ong; Arun Sharma; Alexandra Holmström; Alex C Chang; Michael J Coronado; Antje D Ebert; Joshua W Knowles; Melinda L Telli; Ronald M Witteles; Helen M Blau; Daniel Bernstein; Russ B Altman; Joseph C Wu
Journal:  Nat Med       Date:  2016-04-18       Impact factor: 53.440

2.  Rationale and Design of the SENECA (StEm cell iNjECtion in cAncer survivors) Trial.

Authors:  Roberto Bolli; Joshua M Hare; Timothy D Henry; Carrie G Lenneman; Keith L March; Kathy Miller; Carl J Pepine; Emerson C Perin; Jay H Traverse; James T Willerson; Phillip C Yang; Adrian P Gee; João A Lima; Lem Moyé; Rachel W Vojvodic; Shelly L Sayre; Judy Bettencourt; Michelle Cohen; Ray F Ebert; Robert D Simari
Journal:  Am Heart J       Date:  2018-04-04       Impact factor: 4.749

3.  Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy.

Authors:  Peter J Psaltis; Angelo Carbone; Adam J Nelson; Dennis H Lau; Troy Jantzen; Jim Manavis; Kerry Williams; Silviu Itescu; Prashanthan Sanders; Stan Gronthos; Andrew C W Zannettino; Stephen G Worthley
Journal:  JACC Cardiovasc Interv       Date:  2010-09       Impact factor: 11.195

4.  Doxorubicin Effect on Myocardial Metabolism as a Prerequisite for Subsequent Development of Cardiac Toxicity: A Translational 18F-FDG PET/CT Observation.

Authors:  Matteo Bauckneht; Giulia Ferrarazzo; Francesco Fiz; Silvia Morbelli; Matteo Sarocchi; Fabio Pastorino; Alberto Ghidella; Elena Pomposelli; Maurizio Miglino; Pietro Ameri; Laura Emionite; Flavia Ticconi; Eleonora Arboscello; Ambra Buschiazzo; Elena Augusta Massimelli; Salvatore Fiordoro; Anna Borra; Vanessa Cossu; Annalisa Bozzano; Adalberto Ibatici; Mirco Ponzoni; Paolo Spallarossa; Andrea Gallamini; Paolo Bruzzi; Gianmario Sambuceti; Cecilia Marini
Journal:  J Nucl Med       Date:  2017-06-23       Impact factor: 10.057

Review 5.  Recommendations for genetic testing to reduce the incidence of anthracycline-induced cardiotoxicity.

Authors:  Folefac Aminkeng; Colin J D Ross; Shahrad R Rassekh; Soomi Hwang; Michael J Rieder; Amit P Bhavsar; Anne Smith; Shubhayan Sanatani; Karen A Gelmon; Daniel Bernstein; Michael R Hayden; Ursula Amstutz; Bruce C Carleton
Journal:  Br J Clin Pharmacol       Date:  2016-06-30       Impact factor: 4.335

6.  Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.

Authors:  Brandon C Drafts; Katie M Twomley; Ralph D'Agostino; Julia Lawrence; Nancy Avis; Leslie R Ellis; Vinay Thohan; Jennifer Jordan; Susan A Melin; Frank M Torti; William C Little; Craig A Hamilton; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2013-05-01

7.  Left Ventricular Mass Change After Anthracycline Chemotherapy.

Authors:  Jennifer H Jordan; Sharon M Castellino; Giselle C Meléndez; Heidi D Klepin; Leslie R Ellis; Zanetta Lamar; Sujethra Vasu; Dalane W Kitzman; William O Ntim; Peter H Brubaker; Nathaniel Reichek; Ralph B D'Agostino; W Gregory Hundley
Journal:  Circ Heart Fail       Date:  2018-07       Impact factor: 8.790

8.  Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression.

Authors:  Shashi Kumar Gupta; Ankita Garg; Christian Bär; Shambhabi Chatterjee; Ariana Foinquinos; Hendrik Milting; Katrin Streckfuß-Bömeke; Jan Fiedler; Thomas Thum
Journal:  Circ Res       Date:  2017-11-13       Impact factor: 17.367

9.  Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

Authors:  Siddhartha Jaiswal; Pradeep Natarajan; Alexander J Silver; Christopher J Gibson; Alexander G Bick; Eugenia Shvartz; Marie McConkey; Namrata Gupta; Stacey Gabriel; Diego Ardissino; Usman Baber; Roxana Mehran; Valentin Fuster; John Danesh; Philippe Frossard; Danish Saleheen; Olle Melander; Galina K Sukhova; Donna Neuberg; Peter Libby; Sekar Kathiresan; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-06-21       Impact factor: 91.245

10.  Oncocardiology-Past, Present, and Future: A Review.

Authors:  Edward T H Yeh; Hui-Ming Chang
Journal:  JAMA Cardiol       Date:  2016-12-01       Impact factor: 14.676
View more
  1 in total

1.  Deleterious Effects of Hyperactivity of the Renin-Angiotensin System and Hypertension on the Course of Chemotherapy-Induced Heart Failure after Doxorubicin Administration: A Study in Ren-2 Transgenic Rat.

Authors:  Petr Kala; Hana Bartušková; Jan Piťha; Zdenka Vaňourková; Soňa Kikerlová; Šárka Jíchová; Vojtěch Melenovský; Lenka Hošková; Josef Veselka; Elzbieta Kompanowska-Jezierska; Janusz Sadowski; Olga Gawrys; Hana Maxová; Luděk Červenka
Journal:  Int J Mol Sci       Date:  2020-12-08       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.